Business Context and Reporting Period
Company: Omeros Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: November 9, 2012
Reporting Period: The filing announces financial results for the three and nine months ended September 30, 2012.
Key Financial Metrics
The provided text is a cover report referencing a press release (Exhibit 99.1) for detailed data. The filing text itself does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The filing text does not contain specific comparative data or details regarding material changes versus prior periods. It solely references the issuance of a press release containing these results.
Guidance, Outlook, and Risks
Management Commentary: The report incorporates by reference a press release issued on November 9, 2012, regarding the financial results.
Legal Disclaimer: The information in this 8-K and its exhibit is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 and shall not be incorporated by reference into any other SEC filings by Omeros Corporation.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 9, 2012) for specific revenue, net loss, and cash position figures.
- Verify the specific clinical or operational milestones discussed in the referenced press release, as the 8-K text does not detail them.
- Confirm the company's cash runway and burn rate from the full press release, as liquidity metrics are absent from this summary text.